» Articles » PMID: 30787075

Effect of Text Messaging on Depression in Patients with Coronary Heart Disease: a Substudy Analysis from the TEXT ME Randomised Controlled Trial

Overview
Journal BMJ Open
Specialty General Medicine
Date 2019 Feb 22
PMID 30787075
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We aimed to evaluate the effects on depression scores of a lifestyle-focused cardiac support programme delivered via mobile phone text messaging among patients with coronary heart disease (CHD).

Design: Substudy and secondary analysis of a parallel-group, single-blind randomised controlled trial of patients with CHD.

Setting: A tertiary hospital in Sydney, Australia.

Intervention: The Tobacco, Exercise and dieT MEssages programme comprised four text messages per week for 6 months that provided education, motivation and support on diet, physical activity, general cardiac education and smoking, if relevant. The programme did not have any specific mental health component.

Outcomes: Depression scores at 6 months measured using the Patient Health Questionnaire-9 (PHQ-9). Treatment effect across subgroups was measured using log-binomial regression model for the binary outcome (depressed/not depressed, where depressed is any score of PHQ-9 ≥5) with treatment, subgroup and treatment by subgroup interaction as fixed effects.

Results: Depression scores at 6 months were lower in the intervention group compared with the control group, mean difference 1.9 (95% CI 1.5 to 2.4, p<0.0001). The frequency of mild or greater depressive symptoms (PHQ-9 scores≥5) at 6 months was 21/333 (6.3%) in the intervention group and 86/350 (24.6%) in the control group (relative risk (RR) 0.26, 95% CI 0.16 to 0.40, p<0.001). This proportional reduction in depressive symptoms was similar across groups defined by age, sex, education, body mass index, physical activity, current smoking, current drinking and history of depression, diabetes and hypertension. In particular, the rates of PHQ-9 ≥5 among people with a history of depression were 4/44 (9.1%) vs 29/62 (46.8%) in intervention vs control (RR 0.19, 95% CI 0.07 to 0.51, p<0.001), and were 17/289 (5.9%) vs 57/288 (19.8%) among others (RR 0.30, 95% CI 0.18 to 0.50, p<0.001).

Conclusions: Among people with CHD, a cardiac support programme delivered via mobile phone text messaging was associated with fewer symptoms of mild-to-moderate depression at 6 months in the treatment group compared with controls.

Trial Registration Number: ACTRN12611000161921.

Citing Articles

Partnering RemoTe monitoring of Implanted Cardiac devices with Intelligent PATient Engagement - PARTICIPATE trial: a protocol for a randomised controlled trial.

Sheahen B, Laranjo L, Sivagangabalan G, Shaw T, Thiagalingam A, Chow C Open Heart. 2024; 11(2).

PMID: 39608860 PMC: 11603830. DOI: 10.1136/openhrt-2024-002763.


Persuasive Systems Design Trends in Coronary Heart Disease Management: Scoping Review of Randomized Controlled Trials.

Agyei E, Ekpezu A, Oinas-Kukkonen H JMIR Cardio. 2024; 8:e49515.

PMID: 38896840 PMC: 11222763. DOI: 10.2196/49515.


The Effects of mHealth Interventions on Quality of Life, Anxiety, and Depression in Patients With Coronary Heart Disease: Meta-Analysis of Randomized Controlled Trials.

Hou Q, Liu L, Wu Y J Med Internet Res. 2024; 26:e52341.

PMID: 38861710 PMC: 11200038. DOI: 10.2196/52341.


Efficacy of digital health interventions on depression and anxiety in patients with cardiac disease: a systematic review and meta-analysis.

Kaihara T, Scherrenberg M, Intan-Goey V, Falter M, Kindermans H, Frederix I Eur Heart J Digit Health. 2023; 3(3):445-454.

PMID: 36712158 PMC: 9707908. DOI: 10.1093/ehjdh/ztac037.


Secondary prevention in coronary artery disease: development and content validity of educational messages for mobile phones.

Vieira L, Souza V, de Barros A, de Lima Lopes J, Oliveira L, Santos M Rev Esc Enferm USP. 2023; 56:e20220330.

PMID: 36705551 PMC: 10081665. DOI: 10.1590/1980-220X-REEUSP-2022-0330en.


References
1.
Sharpe M, Walker J, Holm Hansen C, Martin P, Symeonides S, Gourley C . Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet. 2014; 384(9948):1099-108. DOI: 10.1016/S0140-6736(14)61231-9. View

2.
Glozier N, Christensen H, Naismith S, Cockayne N, Donkin L, Neal B . Internet-delivered cognitive behavioural therapy for adults with mild to moderate depression and high cardiovascular disease risks: a randomised attention-controlled trial. PLoS One. 2013; 8(3):e59139. PMC: 3608590. DOI: 10.1371/journal.pone.0059139. View

3.
Muller-Nordhorn J, Kulig M, Binting S, Voller H, Gohlke H, Linde K . Change in quality of life in the year following cardiac rehabilitation. Qual Life Res. 2004; 13(2):399-410. DOI: 10.1023/B:QURE.0000018473.55508.6a. View

4.
Spitzer R, Kroenke K, Williams J . Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999; 282(18):1737-44. DOI: 10.1001/jama.282.18.1737. View

5.
Redfern J, Santo K, Coorey G, Thakkar J, Hackett M, Thiagalingam A . Factors Influencing Engagement, Perceived Usefulness and Behavioral Mechanisms Associated with a Text Message Support Program. PLoS One. 2016; 11(10):e0163929. PMC: 5065147. DOI: 10.1371/journal.pone.0163929. View